News & Press

Gittens Brings Two Decades of Clinical Research Expertise to Trial Interactive Technology Team

NEW YORK, NY, October 28, 2020TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced the hiring of Gillian Gittens as Director of eClinical Strategy and Solutions for the company’s Trial Interactive eClinical platform team.

TransPerfect Life Sciences’ C3 Summit Kicks Off Series of “Conversations on Clinical Content”

Virtual Event Led by TransPerfect’s Trial Interactive eClinical Innovation Team

NEW YORK, May 28, 2020 – TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that Orphan Reach selected TransPerfect’s Trial Interactive cloud-based platform for remote site monitoring, eTMF, and mobile eTMF in support of a phase II COVID-19 study that received 

NEW YORK, April 23, 2020 TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that current and new Trial Interactive eTMF customers will have access to free remote and central monitoring solutions to assist study teams during the COVID-19 pandemic.
 

Leading Remote Trial Management and Risk-Based Monitoring Organization to Use eISF, eTMF, and LMS Solutions

eClinical Platform Designed to Simplify Development and Ensure Inspection Readiness

NEW YORK, NY, August 5, 2019 TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that Symphogen has selected TransPerfect’s Trial Interactive (TI) GlobalLearn learning management system to deliver critical compliance-focused training programs to research personnel to ensure meeting of regulatory standards and overall operational excellence.

NEW YORK, NY, May 10, 2019TransPerfect Life Sciences, a leading provider of services and technologies to support global product development for the life sciences industry, has released version 1.2 of myTI, the mobile application that enables real-time eTMF management and oversight for study teams on the go.

NEW YORK, March 18, 2019TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that Clinipace has selected TransPerfect’s Trial Interactive E-Feasibility and eTMF solutions as part of their ongoing initiative to further cultivate a flexible and responsive infrastructure to support clinical research.

NEW YORK, NY, November 7, 2018TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that Symphogen has selected TransPerfect’s Trial Interactive eTMF and supporting TMF services to centralize and streamline operations for current and future studies.

NEW YORK & PARIS, September 26, 2018 TransPerfect Life Sciences, a leading provider of services and technologies to support global product development for the life sciences industry, today announced a strategic partnership with Arondor.

Charity Race in New York Unites Runners in Fight Against Cancer

NEW YORK, NY, August 23, 2018 – TransPerfect, the world’s largest provider of language and technology solutions for global business, today announced that it has raised $120,000 for the V Foundation for Cancer Research through a combination of employee fundraising, corporate sponsorships, and other efforts related to its TransPerfect Victory Lap 5K Run/Walk.

NEW YORK, NY, May 29, 2018TransPerfect Life Sciences, a leading provider of services and technologies to support global product development for the life sciences industry, today announced the release of version 9.2 of Trial Interactive, their award-winning e-clinical platform.

NEW YORK, February 2, 2018 TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that ARCA Biopharma has selected TransPerfect’s Trial Interactive eTMF solution as their enterprise platform for clinical trials.  
 

NEW YORK, NY, February 13, 2018 - TransPerfect Life Sciences, a leading provider of services and technologies to support clinical trials and product development for the biopharmaceutical industry, today announced the release of myTI, the company’s ground-breaking mobile application that enables real-time eTMF access and functionality for study teams on the go.

NEW YORK, NY, December 5, 2017 TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced the hiring of Christine Morris and Jay Smith, two e-clinical and life sciences veterans, to its leadership team.

NEW YORK, NY, September 13, 2017TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials, today announced the release of Trial Interactive 9.1, the latest version of its award-winning e-clinical platform.

NEW YORK--(BUSINESS WIRE)--TransPerfect Life Sciences, a specialized division of TransPerfect, the world’s largest privately held provider of language and technology solutions for global business, today announced that it is presenting a session at the 2017 Drug Information Association (DIA) Annual Meeting, held June 19-21 in Chicago.

Newest Version of the Award-Winning Technology Enhances Security and Supports More Integrations

E-Clinical Solution Enables Migration to a Paperless Global Trial Process

NEW YORK, NY, October 17, 2016 TransPerfect Life Sciences, a leading provider of global development and commercialization solutions to the life sciences industry, today announced that Agility Clinical has implemented Trial Interactive as its electronic Trial Master File (eTMF).

New Version of Award-Winning Platform Increases Transparency and Visibility

E-Clinical Solution Enables Karyopharm to Move to a Paperless Global Trial Process
 
NEW YORK, NY, April 6, 2016
TransPerfect, a leading provider of global development and commercialization solutions to the life sciences industry, today announced that Karyopharm Therapeutics has implemented Trial Interactive as its electronic Trial Master File (eTMF).
 

Integration Allows Schulman to Streamline eTMF Filing and Compliance for Life Sciences Clients
 
NEW YORK, November 16, 2015
– TransPerfect, a leading provider of global development and commercialization solutions to the life sciences industry, today announced that Schulman IRB has integrated its IRB platform with the Trial Interactive electronic Trial Master File (eTMF) and study start-up solution to streamline global trial management for sponsors and CROs.
 

Join us for a complimentary webinar on Wednesday, June 10 at 1:00 PM EST!

Donna Dorozinsky of DWD & Associates will explore the latest TMF best practices and outline how e-clinical solutions can be employed to streamline clinical processes and prepare for inspection readiness.

Topics discussed:

NEW YORK, NY, May 27, 2015 – The DIA Annual Meeting is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

E-Clinical Solution Enables CTI to Move to a Paperless Global Trial Management Process

NEW YORK, NY, March 10, 2015 – TransPerfect, a leading provider of global development and commercialization solutions to the life sciences industry, today announced that CTI Clinical Trial and Consulting Services (CTI) has implemented Trial Interactive as its electronic Trial Master File (eTMF) and study start-up solution to streamline global trial management for its development programs.

NEW YORK, October 29, 2015TransPerfect, the world’s largest privately held provider of language and technology solutions for global business, today announced Q3 revenues of nearly $130 million, the highest total for this period in the company’s history and more than $10 million ahead of last year’s total for the same quarter.
 

New Location to Serve Growing Demand for Integrated Language Services and Technology Solutions

NEW YORK, October 22, 2014 – TransPerfect, the world’s largest privately held provider of language services and technology solutions, today announced the opening of its newest location in Princeton, New Jersey.

NEW YORK, Jun 16, 2014 - TransPerfect, a leading provider of e-clinical solutions and language services to the life sciences industry, today announced that Cubist has selected Trial Interactive as their electronic Trial Master File (eTMF) enterprise solution across several clinical programs. Trial Interactive is a web-based, 21 CFR Part 11 compliant platform that integrates clinical documentation and trial development.

Award Recognizes Companies Who Demonstrate Leadership in Employing Technology to Advance Global Business

NEW YORK, May 19, 2014TransPerfect, the world's largest privately held provider of language services and translation-related technology solutions, was named the winner of the Global Technology Award at World Trade Week NYC 2014.

TransPerfect Life Sciences to Transform Clinical Development for Biocom Members

NEW YORK, April 22, 2014 – TransPerfect, a leading provider of language services and e-clinical solutions to the life sciences industry, today announced a new partnership with Biocom. Through the multi-year agreement, Biocom members will receive discounted rates on TransPerfect's full suite of services and technology solutions, including virtual data room (VDR) and electronic trial master file (eTMF) platform Trial Interactive.

The implementation of best practices for clinical study and development conduct can streamline administrative burdens for investigator staff as well as study teams, and hopefully yield reduced costs in conducting global clinical development.

By Michael Smyth

Applied Clinical Trials - August 1, 2013

Will Use Trial Interactive PSMF Solution to Meet New European Medicines Agency (EMA) Regulations

NEW YORK, April 22, 2013 – TransPerfect, a leading provider of solutions for global development and commercialization of products to the life sciences industry, announced that Aptalis Pharma ("Aptalis") has implemented Trial Interactive as its global pharmacovigilance system master file (PSMF) solution.

Solution Enables Worldwide Clinical Trials to Streamline and Accelerate Global Study Management

NEW YORK, December 3, 2012 – TransPerfect, a leading provider of eClinical technologies to the life sciences industry, today announced that Worldwide Clinical Trials (WCT) has selected Trial Interactive as its electronic Trial Master File (eTMF) solution to streamline global study management. Trial Interactive is a web-based, 21 CFR Part 11 compliant platform that eliminates the redundancies inherent in paper-based TMF studies.

Trial Interactive Tapped as eTMF Provider

PHILADELPHIA, September 5, 2012 – Premier Research announced today that it will use a new electronic Trial Master File (eTMF) system on all Clinical Development Services Studies. Trial Interactive has been tapped to provide the supporting platform.
 
The adoption of eTMF is the company’s latest investment in its 2012-2013 technology RoadMap focused on three key areas:

Will Use Trial Interactive eTMF Platform to Optimize Global Document Management and Increase Efficiencies in Study Delivery

NEW YORK, May 14, 2012 – TransPerfect, a leading provider of eClinical technologies to the life sciences industry, today announced that INC Research, a therapeutically focused clinical research organization (CRO), has selected Trial Interactive as its global electronic Trial Master File (eTMF) solution. Trial Interactive is a secure, web-based platform that reduces the redundancies inherent in paper-based TMF management.

The Trial Interactive eTMF Platform Allows Pearl to Streamline and Accelerate its Global Study Conduct

Trial Interactive eTMF enhanced with co-developed safety module enables advanced adverse event management

TransPerfect Trial Interactive sponsored the CBI eTMF boot camp in Philadelphia, Pennsylvania (May 19 – 20, 2011).

The conference covered a range of topics related to the various procedures involved in transferring to an electronically hosted trial environment.  Andy Fisher from the MHRA indicated his support for eTMFs, while the various case studies and presentations demonstrated the many advantages of hosting trial documents electronically.

Maximizing Efficiencies in Clinical Trial Submission and Tracking

Newton, MA and New York, NY – February 7, 2011 – New England Institutional Review Board is pleased to announce the launch of a new web-based portal for IRB study management. FastTrack, powered by TransPerfect Trial Interactive, provides a secure platform for the submission, tracking, and exchange of study-related documents between New England IRB and study project teams.

NEW YORK, NY, October 26, 2009 – TransPerfect Trial Interactive today announced a partnership with ConsentSolutions, Inc. to provide collaborative technology solutions to streamline clinical development and clinical trial conduct. This partnership between TransPerfect Trial Interactive and ConsentSolutions combines next-generation tools for electronic informed consent with the industry-wide trend toward paperless processes that simplify document transfer and information access.

Crain's New York Business, Minority Business Report - July 16, 2007

With the top 25 women-owned companies in New York projected to earn over $4 billion in revenues in 2007, it's clear that a woman's place is increasingly at the head of a boardroom table. This figure marks new levels of growth, with the annual increase poised to reach 8.9%.

TransPerfect jumped two places in the ranking this year. Anticipated revenues for 2007 total $150 million, up from $112.8 million last year.

May 21, 2007 - TransPerfect Clinical Development Document Management has opened a new facility in Philadelphia, PA, which will bring comprehensive language support services to the growing legal market in the region. The 6,000-square-foot facility will offer a full suite of services, including electronic data discovery, coding, imaging, printing, and traditional reprographics. The central location in downtown Philadelphia makes TransPerfect Clinical Development Document Management easily accessible to many of the area's leading businesses and law firms.

Entrepreneur - January 2007: 2004 Winner Liz Elting, co-founder of TransPerfect Translations Inc., has seen sales at her New York City global language and business services company skyrocket from $35 million when she won to $113 million in 2006. She's acquired a few companies and added several international and domestic locations along the way. Elting, 40, has also added other services under the TransPerfect banner, such as Staffing, Transcription, and Diversity and Inclusion, a consulting practice that helps companies with diversity training.